Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

Core Viewpoint - A securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. for allegedly making false and misleading statements regarding its financial reporting and business operations during the specified Class Period from August 7, 2024, to February 24, 2025 [1]. Group 1: Allegations Against Maravai - The complaint alleges that Maravai lacked adequate internal controls over financial reporting related to revenue recognition [3]. - It is claimed that Maravai inaccurately recognized revenue on certain transactions during fiscal 2024 [3]. - The lawsuit also states that Maravai's goodwill was overstated, leading to materially misleading positive statements about the company's business and prospects [3]. Group 2: Legal Process and Participation - Investors in Maravai have until May 5, 2025, to seek appointment as a lead plaintiff representative of the class [4]. - A lead plaintiff is typically the investor or small group of investors with the largest financial interest and who are representative of the proposed class [4]. - The decision to serve as a lead plaintiff does not affect an investor's ability to share in any recovery from the lawsuit [4].